Bausch Health (MEX:BHCN) Cyclically Adjusted Revenue per Share: MXN467.05 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:BHCN Bausch Health Companies Inc MEX:BHCN
45 GF Score
Price MXN83.00
GF Value MXN128.65
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Bausch Health Cyclically Adjusted Revenue per Share?

Bausch Health MEX:BHCN 45 Cyclically Adjusted Revenue per Share is MXN467.05 as of Jun. 2026. GuruFocus rates MEX:BHCN with a GF Score™ of 45/100 and a GF Value™ of MXN128.65 (Possible Value Trap). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Bausch Health's adjusted revenue per share for the three months ended in Jun. 2026 was MXN131.617. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is MXN467.05 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Bausch Health's average Cyclically Adjusted Revenue Growth Rate was -0.30% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 2.30% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 6.10% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 10.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Bausch Health was 24.90% per year. The lowest was 2.30% per year. And the median was 11.45% per year.

As of today (2026-08-10), Bausch Health's current stock price is MXN83.00. Bausch Health's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 was MXN467.05. Bausch Health's Cyclically Adjusted PS Ratio of today is 0.18.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Bausch Health was 2.58. The lowest was 0.16. And the median was 0.90.


Bausch Health  (MEX:BHCN) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Bausch Health's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=83.00/467.05
=0.18

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Bausch Health was 2.58. The lowest was 0.16. And the median was 0.90.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Bausch Health Cyclically Adjusted Revenue per Share Related Terms


Bausch Health Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Bausch Health's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bausch Health Cyclically Adjusted Revenue per Share Chart

Bausch Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 527.20 579.60 543.16 493.93 514.27

Bausch Health Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 523.59 531.11 514.27 656.40 467.05

MEX:BHCN vs ZTS: Cyclically Adjusted Revenue per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Bausch Health's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bausch Health Cyclically Adjusted PS Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bausch Health's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Bausch Health's Cyclically Adjusted PS Ratio falls into.


MEX:BHCN
45GF Score
Bausch Health Companies Inc MEX:BHCN
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bausch Health Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Bausch Health's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=131.617/133.5265*133.5265
=131.617

Current CPI (Jun. 2026) = 133.5265.

Bausch Health Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 137.147 101.765 179.952
201612 141.672 101.449 186.469
201703 113.296 102.634 147.398
201706 115.292 103.029 149.420
201709 114.307 103.345 147.690
201712 120.341 103.345 155.487
201803 103.349 105.004 131.422
201806 119.027 105.557 150.566
201809 113.667 105.636 143.678
201812 118.346 105.399 149.929
201903 111.319 106.979 138.943
201906 117.403 107.690 145.569
201909 123.752 107.611 153.554
201912 118.924 107.769 147.347
202003 133.496 107.927 165.160
202006 108.102 108.401 133.158
202009 132.003 108.164 162.955
202012 123.689 108.559 152.136
202103 116.126 110.298 140.582
202106 116.626 111.720 139.390
202109 119.248 112.905 141.028
202112 125.101 113.774 146.820
202203 105.846 117.646 120.134
202206 109.255 120.806 120.759
202209 113.251 120.648 125.340
202212 117.912 120.964 130.158
202303 96.451 122.702 104.960
202306 101.201 124.203 108.798
202309 106.687 125.230 113.755
202312 111.647 125.072 119.194
202403 97.415 126.258 103.023
202406 118.917 127.522 124.517
202409 134.155 127.285 140.734
202412 144.673 127.364 151.673
202503 125.041 129.181 129.247
202506 127.681 129.892 131.254
202509 130.974 130.287 134.230
202512 133.291 130.366 136.522
202603 120.123 132.262 121.271
202606 131.617 133.527 131.617

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of MXN467.05 mean?
Bausch Health (MEX:BHCN) has a Cyclically Adjusted Revenue per Share of MXN467.05 as of Jun. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Bausch Health and its competitors.
Is Bausch Health's Cyclically Adjusted Revenue per Share too high?
Bausch Health's current Cyclically Adjusted Revenue per Share is MXN467.05. Overall, Bausch Health has a GF Score™ of 45/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Bausch Health's Cyclically Adjusted Revenue per Share compare to ZTS?
Bausch Health's Cyclically Adjusted Revenue per Share of MXN467.05 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Revenue per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Bausch Health and its competitors. Bausch Health's current Cyclically Adjusted Revenue per Share is MXN467.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bausch Health stock overvalued right now?
Based on GuruFocus' analysis, Bausch Health (MEX:BHCN) is currently considered Possible Value Trap. The stock's GF Value™ is MXN128.65, compared to a current price of MXN83.00 — trading 35.5% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is MXN467.05. Bausch Health's overall GF Score™ is 45/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Bausch Health (MEX:BHCN), the current Cyclically Adjusted Revenue per Share is MXN467.05 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bausch Health (MEX:BHCN) Overvalued in 2026?

Based on GuruFocus' analysis, Bausch Health stock appears to be undervalued. The current stock price of MXN83.00 is trading 35.5% below its estimated GF Value™ of MXN128.65. GuruFocus considers Bausch Health to be Possible Value Trap.

Key valuation signals for MEX:BHCN:

  • Cyclically Adjusted Revenue per Share: MXN467.05
  • GF Value™: MXN128.65 vs. price of MXN83.00 (35.5% below fair value)
  • GF Score™: 45/100 with 3 warning signs

No single metric tells the full story. See the MEX:BHCN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Bausch Health Business Description

Address 2150 St Elzear Boulvard West, Laval, QC, CAN, H7L 4A8
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum of its revenue from the Bausch + Lomb segment.
45GF Score

Get the complete analysis for MEX:BHCN

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN83.00
Price
MXN128.65
GF Value